Jennifer Couzin, Momentum Builds for Clinical Trial Registration, ScienceNOW, September 10, 2004. (Access restricted to subscribers.) Couzin reports on a Sept. 9 congressional hearing with FDA official Janet Woodcock, who "suggested that FDA's hands were tied when it came to releasing negative data about a company's trials." Evidently, bills which would require "registry of clinical trials at their inception" are pending in both the House and Senate. "Pharmaceutical companies, however, are pressing for voluntary registration."
Posted by
Garrett at 9/13/2004 09:34:00 AM.
The open access movement:
Putting peer-reviewed scientific and scholarly literature
on the internet. Making it available free of charge and
free of most copyright and licensing restrictions.
Removing the barriers to serious research.
I recommend the OA tracking project (OATP) as the best way to stay on top of new OA developments. You can read the OATP feed on a blog-like web page or subscribe to it by RSS, email, or Twitter. You can also help build the feed by tagging new developments you encounter.
